Simultaneous gas chromatographic determination of lorcainide hydrochloride and three of its principal metabolites in biological samples
- PMID: 541407
- DOI: 10.1016/s0378-4347(00)81185-8
Simultaneous gas chromatographic determination of lorcainide hydrochloride and three of its principal metabolites in biological samples
Abstract
A method is described for the determination of the antiarrhythmic drug lorcainide hydrochloride and its three main metabolites in plasma, urine, faeces and tissues from man and animals. The procedure involves the extract of the parent drug, its metabolites and the internal standard from the biological materials at different alkaline pH values, back-extraction into sulphuric acid and re-extraction into the organic phase (heptane--isoamyl alcohol). After silylation of the different phenolic and the N-dealkylated metabolites, analyses were carried out by automated gas--liquid chromatography with electron-capture detection. The method has a sensitivity limit of 5 ng for lorcainide, and 10--20 ng for the various metabolites, per millilitre of plasma. The method was applied to urine, faeces, plasma and tissue samples from man and animals. It was also suitable for automatic sample analysis.
Similar articles
-
Clinical pharmacokinetics of the newer antiarrhythmic agents.Clin Pharmacokinet. 1984 Sep-Oct;9(5):375-403. doi: 10.2165/00003088-198409050-00001. Clin Pharmacokinet. 1984. PMID: 6437721 Review.
-
Mass spectral investigation of the metabolites of lorcainide in man.Eur J Drug Metab Pharmacokinet. 1983 Oct-Dec;8(4):351-62. doi: 10.1007/BF03188767. Eur J Drug Metab Pharmacokinet. 1983. PMID: 6673972
-
The use and limitations of deuterated lorcainide in metabolism and pharmacokinetic studies.Biomed Mass Spectrom. 1985 Jan;12(1):38-42. doi: 10.1002/bms.1200120108. Biomed Mass Spectrom. 1985. PMID: 3157409
-
The pharmacokinetics and tissue distribution of the new antiarrhythmic agent lorcainide (R 15889) in rats.Arzneimittelforschung. 1980;30(4):619-21. Arzneimittelforschung. 1980. PMID: 7190402
-
Metabolites of cardiac antiarrhythmic drugs: their clinical role.Ann N Y Acad Sci. 1984;432:75-89. doi: 10.1111/j.1749-6632.1984.tb14510.x. Ann N Y Acad Sci. 1984. PMID: 6441496 Review.
Cited by
-
Bioavailability and saturation of the presystemic metabolism of oral lorcainide therapy initiated in three different dose regimens.Eur J Clin Pharmacol. 1983;24(4):517-9. doi: 10.1007/BF00609895. Eur J Clin Pharmacol. 1983. PMID: 6861866 Clinical Trial.
-
Excretion and metabolism of lorcainide in rats, dogs and man.Eur J Drug Metab Pharmacokinet. 1983 Oct-Dec;8(4):335-49. doi: 10.1007/BF03188766. Eur J Drug Metab Pharmacokinet. 1983. PMID: 6673971
-
Clinical pharmacokinetics of the newer antiarrhythmic agents.Clin Pharmacokinet. 1984 Sep-Oct;9(5):375-403. doi: 10.2165/00003088-198409050-00001. Clin Pharmacokinet. 1984. PMID: 6437721 Review.